Stock listing

OTC:ERGO Entia Biosciences Inc Stock

Follow Entia Biosciences Inc into a list and get an email when it puts out news.

Share price · OTC:ERGO

$0.0023 USD 0.0000 (0.0%)

Close on Nov 13, 2026

Past year +2,200% · daily closes, Nov 13, 2025 – Nov 13, 2026, adjusted for splits
Day range
$0.0023 – $0.0023 USDNov 13, 2026
Market cap
—Left out: too few shares trade to back it
52-week range
$0.0001 – $0.0402 USDLowest and highest trades, Nov 14, 2025 – Nov 13, 2026
Traded on an average day
$0 USDMedian day 0 shares · 53 days with no trades · last 3 months, Aug 13, 2026 – Nov 13, 2026
Entia Biosciences Inc logo

Daily closes

Last 3 months, Aug 13, 2026 – Nov 13, 2026 · OTC:ERGO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00230.00000.0%$0.0023$0.0023$0.00230
$0.0023+0.0013+130.0%$0.0023$0.0023$0.00235,000
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.0010550
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.0010+0.0002+25.0%$0.0010$0.0010$0.001013,500
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0002$0.0008$0.0002150
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.0008+0.0006+300.0%$0.0008$0.0008$0.00082,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020

Splits

1 split · OTC:ERGO · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
OTC:ERGO
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

All Entia Biosciences Inc news

Entia Biosciences Inc on 6ix

News releases
8 in all · newest Feb 24, 2017 · oldest 2015

Valuation

price Nov 13, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
-0.04

Financials

Annual, in USD

Income statement

LineFY2022FY2021FY2020FY2019FY2016FY2015FY2014FY2013FY2012FY2011
Revenue265.5K346.9K656.3K314.7K369.3K403.3K
Cost of revenue91.5K131.0K245.5K131.1K107.5K132.7K
Gross profit174.0K215.9K410.9K183.6K261.8K270.6K
Research and development37.8K73252858
Selling, general and administrative1.25M2.00M2.06M2.69M1.30M1.54M
Operating income-1.17M-1.92M-1.77M-2.68M-1.08M-1.47M
Depreciation and amortization228.5K236.6K206.3K171.9K17.7K32.0K38.0K36.0K21.5K15.1K
EBITDA-1.15M-1.88M-1.73M-2.65M-1.06M-1.46M
Interest expense83.5K172.6K339.7K144.7K262.9K338.9K
Income before tax-1.40M-2.26M-2.30M-3.10M-1.26M-1.73M
Income tax76.9K149.3K339.7K144.7K262.9K338.9K
Net income-1.47M-2.41M-2.64M-3.25M-1.53M-1.73M
Earnings per share, basic-0.05-0.10-0.28-0.43-0.21-0.28

Balance sheet

LineFY2022FY2021FY2020FY2019FY2016FY2015FY2014FY2013FY2012FY2011
Cash and equivalents76.0K24.1K99.5K36.9K13.1K16.6K
Short-term investments0000
Receivables7.97K7.10K243.8K15.2K66.5K36.3K
Inventory69.8K40.3K95.4K138.9K132.1K173.6K
Current assets234.3K128.3K484.7K225.5K244.2K258.4K
Property, plant and equipment18.3K32.7K43.1K62.1K
Goodwill0000
Total assets439.1K448.6K870.7K631.1K463.0K404.9K
Accounts payable652.7K595.3K38061443136.3K
Current liabilities2.11M1.24M987.2K1.58M1.11M599.7K
Long-term debt300.1K000
Total debt1.05M279.2K418.1K423.0K456.3K332.8K
Total liabilities2.41M1.24M987.2K1.58M1.11M664.7K
Shareholders' equity-1.97M-791.2K-116.5K-949.6K-648.3K-259.8K
Shares outstanding28.1M28.1M28.1M28.1M28.1M24.3M9.44M7.53M7.30M6.26M

Cash flow

LineFY2016FY2015FY2014FY2013FY2012FY2011
Cash from operations-715.1K-536.6K-680.3K-766.7K-314.6K-208.7K
Capital spending-7.12K-21.3K-45.5K-64.6K-63.3K-44.0K
Free cash flow-722.2K-557.9K-725.7K-831.3K-377.9K-252.8K
Cash from investing-7.12K-21.3K-45.5K-64.6K-63.3K-31.1K
Cash from financing774.1K482.5K788.3K855.1K374.4K191.4K
Dividends paid0000
Share buybacks0000
Change in cash51.9K-75.3K62.6K23.8K-3.56K-48.4K

Open Financials

Cap table

Built by 6ix from Entia Biosciences Inc’s releases

Common shares
33,660,947
Fully diluted
33,660,947

Fully diluted

LineShares
Common shares33,660,947

Share count over time

CountShares
Nov 22, 202633,660,947

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Marvin S Md Hausman
Other companies: Raptor Pharmaceutical Corp (Director · Aug 23, 2006 – Aug 23, 2006 · Past); GT Biopharma, Inc. (President & CEO, Director · Aug 1, 2006 – Dec 31, 2007 · Past)
Chairman, CSTO, Director · Nov 20, 2012 – Feb 14, 2017 · Past
Philip A SobolDirector · May 18, 2012 – Apr 24, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Entia Biosciences Inc.